Business Context and Reporting Period
This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in metadata) covers the month of December 2024, with a filing date of December 13, 2024. The report discloses an "Other Event" regarding a capital raise.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data point disclosed is the size of a new equity offering.
- Follow-On Offering Size: $8.0 million
- Offering Type: At-the-Market (ATM) under Nasdaq rules
- Announcement Date: December 12, 2024
Material Changes
The material change reported is the initiation of an $8.0 million follow-on offering. The filing text does not provide comparative financial data against prior periods to assess changes in operational performance.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release detailing the pricing of the offering but does not contain specific management commentary on future guidance, operational outlook, or new risk factors within the body of this report. The filing notes that the information is incorporated into the company's Registration Statement on Form F-3 (File No. 333-269091).
Investor Verification Checklist
- Verify the final number of shares issued and the average price per share in the $8.0 million ATM offering.
- Review the full text of the press release (Exhibit 99.1) for details on the use of proceeds.
- Check the Registration Statement on Form F-3 (File No. 333-269091) for updated liquidity and debt covenants.
- Confirm the company's current cash position post-offering, as this filing does not state the pre-offering balance.